Veradermics (MANE) Prepaid Assets (2024 - 2026)

Veradermics (MANE) reported Prepaid Assets of $602000.0 for Q1 2026, up 96.09% quarter-over-quarter from $307000.0 in Q4 2025.

Veradermics (MANE) Prepaid Assets (2024 - 2026) Analysis & Trends

Veradermics has reported Prepaid Assets for 3 years, with the latest figure at $602000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets changed N/A year-over-year to $602000.0; the trailing twelve-month figure through Mar 2026 stood at $602000.0 (changed N/A YoY), and the FY2025 full-year result was $307000.0, up 707.89% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $602000.0, up from $307000.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $602000.0 in Q1 2026, with the low at $38000.0 in Q4 2024.
  • Historically, Prepaid Assets has averaged $315666.7 across 3 years, with a median of $307000.0 in 2025.
  • The largest YoY upside for Prepaid Assets was 707.89% in 2025 against a maximum downside of 707.89% in 2025.
  • Veradermics' Prepaid Assets stood at $38000.0 in 2024, then soared by 707.89% to $307000.0 in 2025, then surged by 96.09% to $602000.0 in 2026.
  • The last three Prepaid Assets figures came in at $602000.0 (Q1 2026), $307000.0 (Q4 2025), and $38000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Veradermics 2.13 Bn 2.13 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 602,000.00
Dec 31, 2025 307,000.00
Dec 31, 2024 38,000.00